Eyeworld

104 September 2016 EW REFRACTIVE demonstrating excellent stability in the capsular bag. The average ac- commodative amplitude by defocus was 3.4 diopters with a range of 2 and 5 diopters, which was stable at all follow-up periods. Binocular visual acuities were about one line better than monocular. There were no adverse events reported. Conclusion: All patients received excellent distance visual acuity. All patients demonstrated good to excel- lent intermediate and near VA with stable distance, intermediate, and near acuities through 24 months. Bilateral implants in eight patients were stable and averaged one-line acuity increase at all distances. Dr. Desai: The holy grail of optimal solutions for presbyopia continues to be an area of intense interest, and this year's contributions to the ASCRS• ASOA Symposium & Congress certainly highlighted the many innovative ap- proaches to this problem. In this paper, Dr. Nichamin presented the long-term outcome data for a novel lenticular approach to presbyopia correction. The FluidVision lens harnesses the natural ability of the ciliary muscles to shift fluid from the haptics to the central op- tic to induce an accommodative change in refractive power. Data presented for 26 eyes with 3 years of follow-up data demonstrated an impressive retention of distance, intermediate, and near vision over that period. The lens was able to produce up to 4 D of subjective accom- modative range on a bilateral defocus curve with reproducible accommoda- tion when objectively measured in an autorefractor. This promising data highlights what may be an exciting new addition to our presbyopia-correcting armamentarium. First reports on 12-month bilateral and 24- to 36-month monocular clinical follow-up results on a fluid-filled injectable accommodating IOL Louis Nichamin, MD, Frik Potgieter, MD, Paul Roux, MBBS, FRCOphth Purpose: To present the first clinical follow-up data on 12-month binoc- ular and up to 36-month monocular results of a new accommodating intraocular lens, consisting of a hollow, fluid-filled hydrophobic acrylic optic and oversized, hollow, fluid-filled haptics, that maintains stable performance when implanted in the capsular bag. Methods: Twenty-six patients were enrolled in this prospective, single-arm, monocular study of the FluidVision AIOL (PowerVision, Belmont, California). Eight of the 26 patients had fellow eye FluidVision implants at about 18 months' follow-up. Typical IOL study inclusion and exclusion crite- ria were employed. Performance was assessed by distance, intermediate, and near visual acuity, manifest and cycloplegic refraction, objective and subjective accommodative ampli- tude, and contrast sensitivity. Fol- low-up points, which included some or all of these measures, were at 3, 6, 12, 18, 24, and 36 months. Results: At the 24-month clinical follow-up, the monocular aver- age best distance corrected visual acuities were: (n=18) distance 0.0 logMAR, intermediate (66 cm) 0.13 logMAR, and near 0.26 logMAR. The standard deviation of refractions from month 1 through 24 was <0.02 (one letter) for all distances Neel Desai, MD, highlighted the best refractive papers at the "Best of ASCRS" session at the 2016 ASCRS•ASOA Symposium & Congress. The papers were chosen from the Best Paper of Session winners. Here are the abstracts from the studies, with Dr. Desai's comments regarding selection. The session was moderated by Eric Donnenfeld, MD, with panelists Reay Brown, MD, Clara Chan, MD, David F. Chang, MD, and Boris Malyugin, MD. Best of ASCRS: Scan to watch video!

• Cover